Merck & Company Inc

Stock Chart, Company Information, and Scan Results

$80.37(as of Aug 7, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Merck & Company Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$80.37
Ticker SymbolMRK
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees73,000
CountyUSA
Market Cap$202,865.9M
EBIDTA29,157.0M
10-Day Moving Average81.10
P/E Ratio12.31
20-Day Moving Average81.62
Forward P/E Ratio9.07
50-Day Moving Average80.29
Earnings per Share6.49
200-Day Moving Average88.20
Profit Margin28.01%
RSI47.80
Shares Outstanding2,497.8M
ATR2.20
52-Week High116.37
Volume10,818,983
52-Week Low72.58
Most Recent Support Level77.53
Book Value49,060.0M
Most Recent Resistance Level81.32
P/B Ratio4.12
Upper Keltner86.56
P/S Ratio3.17
Lower Keltner76.69
Debt-to-Equity Ratio86.56
Next Earnings Date10/30/2025
Cash Surplus-18,030.0M
Next Ex-Dividend Date09/15/2025

This pharmaceutical company is responsible for one of the best-selling drugs worldwide. Their blockbuster drug, Keytruda, is designed to treat certain types of cancer and is the company’s main revenue driver. They are also behind the development of Gardasil—a vaccine for HPV that has helped prevent hundreds of thousands of cases of cervical cancer.

Merck & Company Inc In Our Stock Scanner

As of Aug 08, 2025
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.